NL6507160A - - Google Patents

Info

Publication number
NL6507160A
NL6507160A NL6507160A NL6507160A NL6507160A NL 6507160 A NL6507160 A NL 6507160A NL 6507160 A NL6507160 A NL 6507160A NL 6507160 A NL6507160 A NL 6507160A NL 6507160 A NL6507160 A NL 6507160A
Authority
NL
Netherlands
Application number
NL6507160A
Other versions
NL144945B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6507160A publication Critical patent/NL6507160A/xx
Publication of NL144945B publication Critical patent/NL144945B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
NL656507160A 1964-06-05 1965-06-04 Werkwijze ter bereiding van derivaten van 7-acylaminocefalosporanzuur. NL144945B (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH733864A CH476021A (de) 1964-06-05 1964-06-05 Verfahren zur Herstellung neuer Derivate der 7-Amino-cephalosporansäure
CH549765 1965-04-21

Publications (2)

Publication Number Publication Date
NL6507160A true NL6507160A (en:Method) 1965-12-06
NL144945B NL144945B (nl) 1975-02-17

Family

ID=25697842

Family Applications (1)

Application Number Title Priority Date Filing Date
NL656507160A NL144945B (nl) 1964-06-05 1965-06-04 Werkwijze ter bereiding van derivaten van 7-acylaminocefalosporanzuur.

Country Status (11)

Country Link
US (1) US3355452A (en:Method)
AT (1) AT264002B (en:Method)
BE (1) BE664955A (en:Method)
BR (1) BR6570169D0 (en:Method)
CH (1) CH476021A (en:Method)
DE (1) DE1545679A1 (en:Method)
ES (1) ES313760A1 (en:Method)
FR (1) FR1463831A (en:Method)
GB (1) GB1073828A (en:Method)
NL (1) NL144945B (en:Method)
SE (1) SE350053B (en:Method)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3497504A (en) * 1968-07-10 1970-02-24 Lilly Co Eli Removal of penicillins from cephalosporins
US3905963A (en) * 1972-01-25 1975-09-16 Lilly Co Eli Process for preparing primary 3-carbamoyloxymethyl cephalosporins
US4210750A (en) * 1972-07-27 1980-07-01 Merck & Co., Inc. Process for the preparation of 3-carbamoyl cephalosporins using isocyanates
US4292427A (en) * 1976-11-17 1981-09-29 Merck & Co., Inc. Cephalosporin compounds
US4252974A (en) * 1978-04-07 1981-02-24 Glaxo Group Limited Cephalosporin compounds
ZA791653B (en) * 1978-04-07 1980-05-28 Glaxo Group Ltd Cephalosporin compounds
US4258183A (en) * 1979-04-06 1981-03-24 Glaxo Group Limited Process for the preparation of cephalosporin compounds
US5773435A (en) * 1987-08-04 1998-06-30 Bristol-Myers Squibb Company Prodrugs for β-lactamase and uses thereof
US5338843A (en) * 1992-01-30 1994-08-16 Becton, Dickinson And Company Fluorogenic and chromogenic β-lactamase substrates

Also Published As

Publication number Publication date
SE350053B (en:Method) 1972-10-16
ES313760A1 (es) 1966-03-01
US3355452A (en) 1967-11-28
FR1463831A (fr) 1966-12-30
GB1073828A (en) 1967-06-28
CH476021A (de) 1969-07-31
NL144945B (nl) 1975-02-17
DE1545679A1 (de) 1969-08-07
BE664955A (en:Method)
AT264002B (de) 1968-08-12
BR6570169D0 (pt) 1973-08-16

Similar Documents

Publication Publication Date Title
BE657899A (en:Method)
BE642588A (en:Method)
BE432268A (en:Method)
BE47396A (en:Method)
BE483969A (en:Method)
BE507097A (en:Method)
BE518974A (en:Method)
BE554195A (en:Method)
BE564626A (en:Method)
BE584699A (en:Method)
BE603534A (en:Method)
BE610935A (en:Method)
BE613833A (en:Method)
BE621510A (en:Method)
BE622126A (en:Method)
BE623398A (en:Method)
BE626083A (en:Method)
BE626684A (en:Method)
BE627057A (en:Method)
BE627390A (en:Method)
BE627931A (en:Method)
BE628611A (en:Method)
BE629793A (en:Method)
BE632875A (en:Method)
BE636791A (en:Method)